Attenuation of reperfusion arrhythmias by selective inhibition of angiotensin-converting enzyme/kininase II in the ischemic zone: Mediated by endogenous bradykinin?

Journal of Cardiovascular Pharmacology

Volumn 27, Issue 3, 1996, Pages 428-438

  Shimada, Yasuyuki ^a   Avkiran, Metin ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

ACE kininase; Bradykinin; HOE140; Ramiprilat; Reperfusion arrhythmias

Indexed keywords

ANGIOTENSIN; BRADYKININ; DIPEPTIDYL CARBOXYPEPTIDASE; ICATIBANT; KININASE; RAMIPRILAT;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CORONARY ARTERY; CORONARY ARTERY BLOOD FLOW; HEART ARRHYTHMIA; HEART MUSCLE REPERFUSION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; ISOLATED HEART; NONHUMAN; PRIORITY JOURNAL; RAT; VASOCONSTRICTION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ARRHYTHMIA; BRADYKININ; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; RAMIPRIL; RATS; RATS, WISTAR;

EID: 0030058685     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199603000-00017     Document Type: Article

References (35)

1. van Gilst WH, de Graeff PA, Kingma JH, Wesseling H, de Langen CDJ. Captopril reduces purine loss and reperfusion arrhythmias in the rat heart after coronary artery occlusion. Eur J Pharmacol 1984;100:113-7.
2. van Gilst WH, de Graeff PA, Wesseling H, de Langen CDJ. Reduction of reperfusion arrhythmias in the ischemic isolated rat heart by angiotensin converting enzyme inhibitors: a comparison of captopril, enalapril, and HOE498. J Cardiovasc Pharmacol 1986;8:722-8.
3. de Graeff PA, van Gilst WH, De Langen CD, Kingma JH, Wesseling H. Concentration-dependent protection by captopril against ischemia-reperfusion injury in the isolated rat heart. Arch Int Pharmacodyn Ther 1986;280:181-93.
4. Li K, Chen X. Protective effects of captopril and enalapril on myocardial ischemia and reperfusion damage of rat. J Mol Cell Cardiol 1987;19:909-15.
5. Rochette L, Ribuot C, Belichard P, Bril A, Devissaguet M. Protective effect of angiotensin converting enzyme inhibitors (CEI): captopril and perindopril on vulnerability to ventricular fibrillation during myocardial ischemia and reperfusion in rat. Clin Exp Hypertens[A] 1987;9:365-8.
6. Linz W, Schölkens BA, Han YF. Beneficial effects of the converting enzyme inhibitor, ramipril, in ischemic rat hearts. J Cardiovasc Pharmacol 1986;8 (suppl 10):s91-9.
7. Fleetwood G, Boutinet S. Meier M, Wood JM. Involvement of the renin-angiotensin system in ischemic damage and reperfusion arrhythmias in the isolated perfused rat heart. J Cardiovasc Pharmacol 1991;17:351-6.
8. Arad M, Shontan A, Horowitz L, Klein R, Rabinowitz B. Effects of captopril on metabolic and hemodynamic alterations in global ischemia and reperfusion in the isolated working rat heart. J Cardiovasc Pharmacol 1992;19:319-23.
9. Pahor M, Gambassi G, Carbonin P. Antiarrhythmic effects of ACE inhibitors: a matter of faith or reality? Cardiovasc Res 1994;28:173-82.
10. van Wijngaarden J, Tio RA, van Gilst WH, de Graeff PA, de Langen CDJ, Wesseling H. Basic pharmacology of ACE- inhibitors with respect to ischaemic heart disease: prostaglandins and bradykinin. Eur Heart J 1990;11 (suppl B): 84-93.
11. Linz W, Wiemer G, Gohlke P, Unger T, Schölkens BA. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol Rev 1995;47:25-49.
12. Parratt JR. Endogenous myocardial protective (antiarrhythmic) substances. Cardiovasc Res 1993;27:693-702.
13. Linz W, Martorana PA, Schölkens BA. Local inhibition of bradykinin degradation in ischemic hearts. J Cardiovasc Pharmacol 1990;15:99-109.
14. Baumgarten CR, Linz W, Kunkel G, Schölkens BA, Wiemer G. Ramiprilat increases bradykinin outflow from isolated hearts of rat. Br J Pharmacol 1993;108:293-5.
15. Maxwell MP, Hearse DJ, Yellon DM. Species variation in the coronary collateral circulation during regional myocardial ischaemia: a critical determinant of the rat of evolution and extent of myocardial infarction. Cardiovasc Res 1987;21:737-46.
16. Avkiran M, Curtis MJ. Independent dual perfusion of left and right coronary arteries in isolated rat hearts. Am J Physiol 1991;261:H2082-90.
17. Unger T, Gohlke P. Converting enzyme inhibitors in cardiovascular therapy: current status and future potential. Cardiovasc Res 1994;28:146-58.
18. Hock FJ, Wirth K, Albus U, et al. HOE140 a new potent and long acting bradykinin antagonist: in vitro studies. Br J Pharmacol 1991;102:769-73.
19. 1 adrenergic stimulation: a potential role for receptor mediated activation of sarcolemmal sodium- hydrogen exchange. Cardiovasc Res 1995;29:222-30.
20. Walker MJ, Curtis MJ, Hearse DJ, et al. The Lambeth Conventions: guidelines for the study of arrhythmias in ischemia, infarction, and reperfusion. Cardiovasc Res 1988;22:447-55.
21. Avkiran M, Ibuki C. Reperfusion induced arrhythmias: a role for washout of extracellular protons? Circ Res 1992;71:1439-40.
22. + exchange and reperfusion arrhythmias: protection by intracoronary infusion of a novel inhibitor. Am J Physiol 1994;267: H2430-40.
23. Wallenstein S, Zucker CL, Fleiss JL. Some statistical methods useful in circulation research. Circ Res 1980;47:1-9.
24. Ibuki C, Hearse DJ, Avkiran M. Rate of reflow and reperfusion induced arrhythmias: studies with dual coronary perfusion. Cardiovasc Res 1992;26:316-23.
25. Unger T, Ganten D, Lang RE, Schölkens BA. Is tissue converting enzyme inhibition a determinant of the antihypertensive efficacy of converting enzyme inhibition? Studies with the two different compounds, Hoe498 and MK421, in spontaneously hypertensive rats. J Cardiovasc Pharmacol 1984;6:872-80.
26. Yamada H, Fabris B, Allen AM, Jackson B, Johnston CI, Mendelsohn AO. Localization of angiotensin converting enzyme in rat heart. Circ Res 1991;68:141-9.
27. Challah M, Nicoletti A, Arnal JF, et al. Cardiac angiotensin converting enzyme overproduction indicates interstitial activation in renovascular hypertension. Cardiovasc Res 1995;30:231-9.
28. 2- receptors in endothelial cells and isolated ischemic rat hearts. Pharm Pharmacol Lett 1993;3:24-7.
29. Vegh A, Szekeres L, Parratt JR. Local intracoronary infusions of bradykinin profoundly reduce the severity of ischaemia-induced arrhythmias in anaesthetized dogs. Br J Pharmacol 1991;104:294-5.
30. Vegh A, Papp JG, Szekeres L, Parratt JR. Prevention by an inhibitor of the L-arginine-nitric oxide pathway of the anti- arrhythmic effects of bradykinin in anaesthetized dogs. Br J Pharmacol 1993;110:18-9.
31. 2 receptors in adult myocardium and neonatal rat cardiomyocytes. Circ Res 1995;76:773-80.
32. Rubin LE, Levin R. Protective role of bradykinin in cardiac anaphylaxis: coronary-vasodilating and antiarrhythmic activities mediated by autocrine/paracrine mechanisms. Circ Res 1995;76:434-40.
33. Manning AS, Hearse DJ. Reperfusion-induced arrhythmias: mechanisms and prevention. J Mol Cell Cardiol 1984;16:497-518.
34. Schunkert H, Dzau VJ, Tang SS, Hirsch AT, Apstein CS, Lorell BH. Increased rat angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy: effects on coronary resistance, contractility, and relaxation. J Clin Invest 1990;86:1913-20.
35. Eberli FR, Apstein CS, Ngoy S, Lorell BH. Exacerbation of left ventricular ischemic diastolic dysfunction by pressure- overload hypertrophy. Modification by specific inhibition of cardiac angiotensin converting enzyme. Circ Res 1992;70:931-43.